HSCB £4.75m Community Pharmacy Staff Funding – Reminder to
complete and return the Appendix A Declaration to HSCB by Tuesday 10th
November 2020
I write to remind you to complete and submit Appendix A,
contained within the £4.75m Staff funding allocation letter from Joe Brogan
dated 27th October 2020, to HSCB offices on or before Tuesday 10th
November 2020 so that HSCB can process the payment(s) to the pharmacy(-ies)
you operate.
Please ensure that a separate Appendix A form is completed
and submitted to HSCB for each pharmacy you operate.
You will be aware that in order to avail of the funding you will
have to complete and retain an outline plan, Appendix B to the letter,
summarising how you intend to utilise the funding to support the continued
delivery of pharmacy services for the period up to March 2021.
The following may assist you in drafting the plan for each of
the pharmacies you operate:-
Review and identify the increased staff costs you
incurred in the period July 2020 to date.
Consider the additional staff costs you identified for
the period March 2020 – June 2020 and which were included in the Staff
Funding Assurance return that you submitted to HSCB in June. These can be
used to benchmark the range and quantum of additional staff costs that you
might reasonably anticipate incurring through to March 2021.
Consider the attached CPNI Assurance Template Factsheet
to identify any other additional staff cost elements that may be relevant
to the pharmacy(-ies) you operate.
Upon completion, Appendix B should be retained so that you can use it in the follow-up Staff Funding Assurance process that HSCB will undertake in due course.
In summary
Complete and return Appendix A for each
pharmacy you operate to HSCB on or before 10th November 2020.
Complete and retain Appendix B for each pharmacy you
operate for future reference and use.
Please do not hesitate to contact CPNI offices should you require any additional information.
Contact Details for Local Integrated Care Offices:
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
*** FOR THE ATTENTION OF CONTRACTORS PROVIDING FLU VACCINATION SERVICE FOR HEALTH & SOCIAL CARE WORKERS ONLY ***
Dear Colleague
COMMUNITY PHARMACY SEASONAL FLU VACCINATION SERVICE (CPFV) –
PAYMENT MONITORING AND ACTIVITY DATES
Please find attached for your attention, correspondence from Joe
Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines
Management.
If there are any queries in relation to payment for the CPFV service, please contact Gail Carland at the Pharmaceutical Payments department at BSO Tel: 028 9536 3846, Email: Gail.Carland@hscni.net.
Yours sincerely
SENT FOR AND BEHALF
OF GERARD GREENE | Chief Executive
Download
Dear Colleague,
Further Call for Return of Unused Oxygen Cylinders
HSCB colleagues have again asked us to urge all community
pharmacies to return any oxygen cylinders that are not in use to BOC.
This would include any cylinders from patients’ homes that are no longer
required. We appreciate it is difficult for community pharmacy to know
what cylinders may be in patients’ homes, but if you can remind patients to
return any of their cylinders it would be greatly appreciated at this
challenging time.
As with any patient returns at this time, caution should be
taken when accepting returns, and appropriate decontamination measures should
be taken. We have attached the poster (previously circulated in March) to
this email, you may wish to display this in your pharmacy.
Any assistance you can provide would be welcomed to support
ongoing work to deal with the COVID-19 situation.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
Dear Colleague
ACTIONS IN EVENT OF CLOSURES AND SUBMISSION OF SIT-REPS
Please find attached for your attention, correspondence from Joe
Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines
Management.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
Dear
Colleague
REMINDER – PROVISION OF OXYGEN THERAPY TO NEW PATIENTS IN CARE
HOME SETTINGS
Please find attached for your attention, correspondence from Joe
Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines
Management.
Yours sincerely
SENT FOR AND BEHALF
OF GERARD GREENE | Chief Executive
Download
Dear contractor
EU Exit
CPNI
recently represented Northern Ireland contractors at the reconvened Community
Pharmacy Brexit Forum, a UK-wide group which brings together more than 20
organisations across the pharmacy, wholesale and wider primary care sectors, to
discuss Brexit/EU Exit matters. The Northern Ireland Department of Health was
also represented.
The
group was established in preparation for previous Brexit deadlines and is
accelerating its work ahead of the end of the Transition Period on 31 December
2020. The Forum’s aim is to bring together the sector and policy makers,
and ultimately to try to ensure that the community pharmacy sector and patients
are not adversely affected by Brexit/EU Exit.
The
focus of the Forum was medicines supply, with members concerned about the potential
impact of Brexit/EU Exit on patients, particularly with COVID-19 challenges
likely to continue at a time of increased winter pressures.
CPNI
(along with other Forum members) sought greater clarity around supplies of
medicines from the EU and Great Britain to Northern Ireland after 31 December
2020. The need to maintain current prescribing periods on prescriptions ahead
of, and beyond, the end of the Transition period was also highlighted as a
necessary step to reduce the risk of supply disruption.
The
Forum heard from both the Department of Health and Social Care and NHS England
& NHS Improvement about the preparations being made to manage any potential
risks to supply and to deal with medicines shortages. There was a
consensus among pharmacy stakeholders that increased communications would help
address patient concerns and expectations, and it was agreed that a
communications group will be convened.
CPNI has also engaged directly with
national and local Department of Health officials in highlighting concerns in
respect of medicines supplies and will continue to work with officials for
urgent and Northern-Ireland specific resolution to these matters.
CPNI will continue to keep
contractors and their teams updated as these matters progress.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.